Treatment with chemokine receptor inhibitors impairs the infiltration of MDSCs and tumor-associated macrophages to the tumor microenvironment to abolish their immunosuppressive function against cytotoxic CD8+ T cells [88,95]. Here, CD8A is linked to neoplasm.